From: P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas
Low-grade
High-grade
(No. of cases)
KRAS mutation
MAPK +
5
1
MAPK –
7
Wild KRAS
2
11
3
43
Total cases
62